iconoEstudios Activos

  • THC-GEINO 1601 – Phase Ib clinical trial, multicenter study to evaluate the combination of THC – CBD with Temozolomide and radiotherapy in patients with newly diagnosed glioblastoma.
  • GEINOGLAS 1602 – Phase 1b/ randomized phase II Study Combining Glasdegib (SHH pathway inhibitor) with temozolomide in patients with newly diagnosed Glioblastoma.